These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 6092459)
21. Antidisialoganglioside ricin A-chain immunotoxins show potent antitumor effects in vitro and in a disseminated human neuroblastoma severe combined immunodeficiency mouse model. Gottstein C; Schön G; Tawadros S; Kube D; Wargalla-Plate UC; Hansmann ML; Wacker HH; Berthold F; Diehl V; Engert A Cancer Res; 1994 Dec; 54(23):6186-93. PubMed ID: 7954465 [TBL] [Abstract][Full Text] [Related]
22. Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells. Kirch ME; Hammerling U J Immunol; 1981 Aug; 127(2):805-10. PubMed ID: 6788849 [TBL] [Abstract][Full Text] [Related]
23. Genetic engineering of immunotoxins. Youle RJ; Greenfield L; Johnson VG Cancer Treat Res; 1988; 37():113-22. PubMed ID: 2908621 [No Abstract] [Full Text] [Related]
24. Historical development of monoclonal antibody therapeutics. Nissim A; Chernajovsky Y Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939 [TBL] [Abstract][Full Text] [Related]
25. Idiotypes of anti-myoglobin antibodies: shared idiotypes among monoclonal antibodies to distinct determinants of sperm whale myoglobin. Kohno Y; Berkower I; Minna J; Berzofsky JA J Immunol; 1982 Apr; 128(4):1742-8. PubMed ID: 6174613 [No Abstract] [Full Text] [Related]
26. Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index. Junutula JR; Raab H; Clark S; Bhakta S; Leipold DD; Weir S; Chen Y; Simpson M; Tsai SP; Dennis MS; Lu Y; Meng YG; Ng C; Yang J; Lee CC; Duenas E; Gorrell J; Katta V; Kim A; McDorman K; Flagella K; Venook R; Ross S; Spencer SD; Lee Wong W; Lowman HB; Vandlen R; Sliwkowski MX; Scheller RH; Polakis P; Mallet W Nat Biotechnol; 2008 Aug; 26(8):925-32. PubMed ID: 18641636 [TBL] [Abstract][Full Text] [Related]
27. The history of ricin, abrin and related toxins. Olsnes S Toxicon; 2004 Sep; 44(4):361-70. PubMed ID: 15302520 [TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies: the possibilities for cancer therapy. Poynton CH; Reading CL Exp Biol; 1984; 43(1):13-33. PubMed ID: 6398221 [TBL] [Abstract][Full Text] [Related]
29. "Hidden" cytotoxic antibodies that react with allogeneic cultured fetal and tumor cells contained in soluble immune complexes from normal human sera. Morgan AC; Rossen RD; McCormick KJ; Stehlin JS; Giovanella BC Cancer Res; 1982 Mar; 42(3):881-7. PubMed ID: 7059986 [TBL] [Abstract][Full Text] [Related]
30. The construction of a mouse/human chimeric antibody against human breast cancer cells. Meulemans E; Vandevyver C; Volckaert G; Raus J Year Immunol; 1993; 7():131-6. PubMed ID: 8372502 [No Abstract] [Full Text] [Related]
37. Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody-ricin conjugate. Thorpe PE; Mason DW; Brown AN; Simmonds SJ; Ross WC; Cumber AJ; Forrester JA Nature; 1982 Jun; 297(5867):594-6. PubMed ID: 7088145 [No Abstract] [Full Text] [Related]
39. [Christmas-time in the history of medicine]. Kiss L Lege Artis Med; 2011 Dec; 21(12):820-2. PubMed ID: 22397165 [No Abstract] [Full Text] [Related]
40. The preparation and cytotoxic properties of antibody-toxin conjugates. Thorpe PE; Ross WC Immunol Rev; 1982; 62():119-58. PubMed ID: 7042536 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]